Vanderbilt Basic Sciences
-
Interview with a Vampire: Sesame Street’s Count von Count
Vice Dean Chuck Sanders conducted his annual Halloween Interview, this time with Sesame Street’s Count von Count, a much loved and highly respected expert on teaching numerical skills to children. Here is a transcript of their conversation. CS: Mr. von Count, let me say what an incredible honor it… Read MoreOct. 1, 2023
-
$3M NSF grant to advance biomanufacturing
A team of Vanderbilt engineers, biologists and education specialists have received a $3 million grant from the National Science Foundation to advance large-scale biomanufacturing of cell-derived nanoparticles that can deliver precisely targeted drugs to the site of a disease. The grant is part of the NSF’s Future Manufacturing program that is… Read MoreSep. 28, 2023
-
Top five things to consider when preparing to purchase freezers for research labs
Top five things to consider when preparing to purchase freezers for research labs By Selene Colon Research laboratories require reliable and efficient freezers to store various samples, including biological specimens, enzymes, antibodies, and other temperature-sensitive reagents. Second only to fume hoods, your lab’s cold storage (refrigerators, freezers, cold rooms) is… Read MoreSep. 26, 2023
-
Basic Sciences names Hasty senior associate dean for faculty
By Aaron Conley Alyssa Hasty, PhD Alyssa Hasty, Cornelius Vanderbilt Professor of molecular physiology and biophysics and associate dean for faculty in the School of Medicine Basic Sciences, has been promoted to senior associate dean for faculty. “Since 2017, Alyssa’s strong leadership has been invaluable for shaping faculty development, culture,… Read MoreSep. 25, 2023
-
SOM Enabling Innovation Initiative FAQs
I have a concept or prototype for an invention, biological material, software, or document/content (“matter”) that I think should be legally protected as my intellectual property. What should I know and what should I do? Document the conceptualization and development of your “matter” in writing (as in a lab… Read MoreSep. 22, 2023
-
NIH’s clarifying guidance for oversight of foreign sub-awards
The NIH has released its final guide notice clarifying its longstanding policy on foreign sub-award and consortium agreements. This applies to all U.S. NIH grants with a sub-contract to a foreign institution. This guide is in response to audits conducted by the Office of the Inspector General… Read MoreSep. 21, 2023
-
Erin Calipari receives $2M to study how alcohol use disorder develops in the brain
Erin Calipari, associate professor of pharmacology and associate director of the Vanderbilt Center for Addiction Research, has received a grant of nearly $2 million from the National Institute on Alcohol Abuse and Alcoholism to understand what happens in the brain that makes… Read MoreSep. 13, 2023
-
Vanderbilt scientists make headway in drug development to cure pulmonary arterial hypertension
Research by David Merryman and Craig Lindsley has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without serious neurological side effects. The article, “Development of a Peripherally Restricted… Read MoreSep. 13, 2023
-
Nancy Carrasco receives 2024 Award for the Biophysics of Health and Disease
Nancy Carrasco, MD Please join us in congratulating Nancy Carrasco, Joe C. Davis Chair in Biomedical Science and chair of the Department of Molecular Physiology and Biophysics, for receiving the 2024 Award for the Biophysics of Health and Disease from the Biophysical Society. Carrasco’s lab focuses on understanding… Read MoreSep. 13, 2023
-
Foundation funds research to block drug resistance in cancer treatment
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug… Read MoreSep. 1, 2023